Related Experiment Video
Updated: Apr 21, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Anterior Horn Cell Disease in Adulthood: Unmasking Spinal Muscular Atrophy Type 4
Shamas Rafique1,2,3,4, Aya Odeh5
1Family Medicine, Family Medical Health Care PLLC, New York, USA.
Abstract:
Spinal muscular atrophy (SMA) type 4 is a rare, adult-onset motor neuron disorder characterized by slowly progressive proximal weakness with preserved ambulation. Its indolent clinical course and nonspecific early manifestations frequently result in prolonged diagnostic delays. We present the complete diagnostic evaluation of a 33-year-old male patient with a multi-year history of painless, progressive lower extremity weakness. Initial laboratory testing revealed an isolated elevation of creatine kinase (CK) and vitamin D deficiency, with otherwise normal metabolic, endocrine, and inflammatory studies. Persistent CK elevation despite vitamin repletion prompted a neuromuscular referral. Electrodiagnostic testing demonstrated normal nerve conduction studies with electromyographic evidence of widespread chronic active denervation and, critically, normal paraspinal musculature. This pattern strongly supported the localization of the pathology to the anterior horn cells. Subsequent genetic testing confirmed a homozygous deletion of exon 7 in the SMN1 gene, establishing the definitive diagnosis of SMA type 4. This case underscores the importance of a systematic diagnostic approach integrating serial CK monitoring, electrodiagnostic localization, and genetic confirmation in evaluating adult-onset proximal weakness, particularly in the current era of disease-modifying therapies.
More Related Videos
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
09:07Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
Published on: September 25, 2015
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis ll: Pathophysiology
Huntington Disease l: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Multiple Sclerosis l: Introduction